Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludroxycortide versus imiquimod for actinic cheilitis
RBR-4msk3ygNot yet recruiting
- Sponsor
- Fernanda Gonçalves Salum
- Start
- Nov 2023
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in actinic cheilitis (AC) comparing Fludroxycortide cream with Imiquimod cream (2 arms). Planned start Nov 2023; status: not yet recruiting.
02
Drugs
Flurandrenolide acetateimiquimod
03
Conditions
actinic cheilitis (AC)
Beyond the preview
Go deeper on RBR-4msk3yg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4msk3yg.